Human Technopole: a new building for scientific research
03 April 2020
Human Technopole: a new building for scientific research
Milan, 3 April 2020 – Ten floors high, over 16.500 square meters exclusively dedicated to research laboratories and 3.000 square meters of terraces and green areas: a snapshot of the project for the new Human Technopole building, Italy’s research institute for life sciences based at the heart of MIND Milano Innovation District. The building which aims to be modern as well as welcoming, will be the main headquarters of scientific laboratories and the centre of Human Technopole’s campus.
The name of the designer who won the international competition for the design of the building and the campus was announced today by Human Technopole Foundation and Arexpo: the winner is Piuarch, a firm based in Milan which has contributed to many major redevelopment projects in the city, including the Mecenate District and the area of Porta Nuova.
An investment of up to 94.5 million euros is planned for the construction of the new building.
The Human Technopole Campus includes three existing buildings, Palazzo Italia the iconic Milan EXPO 2015 pavilion, a North Pavilion and a South Pavilion and will cover an overall area of over 11.000 square meters. The project describes how the different buildings will be interconnected as well as how connections with external areas will be developed.
The new building will rise within the area of the campus and is expected to be built in 1.100 consecutive days, equivalent to about three years. It will have an overall surface of 35.000 square meters and at its highest point will be 61 meters high. It will host biochemistry and molecular biology laboratories, cutting edge scientific technology including light microscopy, space for an extension of HT’s Cryo-EM facility as well as 800 workstations for researchers. In addition, large common areas, meeting rooms and classrooms for events and trainings will be available.
Human Technopole researchers have identified the molecular mechanisms by which the membrane receptor sortilin binds thyroglobulin along its pathway to the release of thyroid hormones within the thyroid gland. The results of the research were published in Nature Communications and highlight that sortilin senses thyroglobulin via a short flexible “tag” which appears to be a common motif for the recognition of other partner proteins throughout our body.
The AI4Life project, co-led by Florian Jug (Computational Biology Research Centre at Human Technopole) and Anna Kreshuk (EMBL), received the highest possible score in the European Commission’s final review, recognising its scientific impact and the quality of its achievements in applying artificial intelligence to biological image analysis.
The Giustacchini Group of the Genomics Research Centre of Human Technopole has been awarded a €1.66 million grant from the Fondo Italiano per la Scienza (FIS 2) to advance precision immunotherapy for haematological malignancies. The three-year project, titled “Tailoring Precision Immunotherapy to Haematological Malignancies”, aims to develop more effective cell-based therapies for blood cancers by integrating molecular, cellular and systems-level analyses.
Turning scientific discoveries into real-world therapies was the focus of the second international conference “Future Trends in Translational Medicine – From Molecules to Therapies,” held at the Complesso Universitario di San Giovanni a Teduccio in Naples on 30 -31 October 2025.
As 2025 comes to a close, we look back at a year shaped by connection, discovery and growth. At Human Technopole, progress happens when perspectives meet, between disciplines, technologies and people. Our holiday card captures this idea visually: what looks like a festive forest is actually a colon under the microscope, a structure that changes depending on how you look at it, reminding us that science often begins with a shift in perspective.
Manage Cookie Consent
This website uses technical cookies to provide you with a better browsing experience and, subject to your consent, profiling cookies to offer you information and advertising in line with your preferences. For more details, you can consult our cookie policy by clicking on the link below, or set your preferences by clicking "set preferences". By selecting "accept cookies" you consent to the use of all types of cookies while you can revoke your consent by clicking on "refuse". By deciding to refuse or closing the banner, only the technical cookies necessary for the correct functioning of the site will be activated.
Technical cookies (required)
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Third party cookies for statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Third party cookies for profiling
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.